Companies Profiled in In-vitro Diagnostics Market are Danaher Corporation, Sorin Group, Abbott, Thermo Fisher Scientific, bioMérieux, QIAGEN, Grifols, Luminex Corporation

Rising number of cancer cases in Asian as well as western countries should drive in-vitro diagnostic services industry growth in upcoming years. According to Livemint in 2016, India had over 3.9 million cases of cancer that will accelerate the demand for in-vitro diagnostic services. Moreover, growing elderly population suffering from chronic diseases such as diabetes and cardiovascular disorders will influence the industry growth. In the U.S., there are around 78 million people in the age group of 65 years and above. Majority of elderly people suffer from at least one chronic disease or infection that should upsurge the demand for in-vitro diagnostic services in near future.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2820

Software segment will grow at 4.5% over the forecast timeframe due to growing preference for reliable and efficient diagnostic software that will help to maintain patient’s record. Also, software enables analysis of the gene sequencing information that will boost drug discovery process and is expected to render positive impact on segmental growth. In-vitro diagnostic companies such as Roche have partnered with Microsoft and Cleidon that will help in broadening its software offerings and will also prove beneficial for business growth.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Abbott
• Thermo Fisher Scientific
• bioMérieux
• QIAGEN
• Grifols
• Danaher Corporation
• Sorin Group
• Luminex Corporation Roche Diagnostics Middle East
• Becton Dickinson
• BioRad

Point-of-care testing segment accounted for 23.5% revenue share in 2017 and is expected to grow over the forecast timeframe. Technological advancements coupled with increasing prevalence of genetic diseases requiring critical monitoring should increase demand for point-of-care testing that will upsurge the segment growth in forthcoming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2820

U.S. dominated North America in-vitro diagnostic services market and was valued at USD 16.7 billion in 2017 as a result of increasing demand for diagnostic services and growing adoption rate of software. Development in public healthcare system will increase the availability of superior quality diagnostic services that should impel industry growth in upcoming years.

In-vitro Diagnostics Market, By Product Type (USD million)
o Reagents & kits
o Instruments

In-vitro Diagnostics Market, By Service Type (USD million)
o Data Management Software
o Services

In-vitro Diagnostics Market, By Technology (USD million)
o Clinical Chemistry
o Immunoassay/Immunochemistry
o Molecular Diagnostics
o Hematology
o Microbiology
o Coagulation and Hemostasis
o Urinalysis

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.